Close association of Chlamydia pneumoniae IgA seropositivity by ELISA with the presence of coronary artery stenosis in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 20, Issue 9, 2005, Pages 1944-1950

  Nishimura, Masato ^a   Hashimoto, Tetsuya ^a   Kobayashi, Hiroyuki ^a   Fukuda, Toyofumi ^a   Okino, Koji ^a   Yamamoto, Noriyuki ^a   Mashida, Chikako ^b   Kawagoe, Kiyotaka ^b   Fujita, Hiroshi ^c   Inoue, Naoto ^c   Takahashi, Hakuo ^d   Ono, Toshihiko ^a  

^a Toujinkai Hospital   (Japan)

^b Showa Denko Materials Co   (Japan)

^c KYOTO SECOND RED CROSS HOSPITAL   (Japan)

^d KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Chlamydia pneumoniae; Coronary artery disease; ELISA; End stage renal disease; Haemodialysis; IgA

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR;

AGED; ANTIBODIES, BACTERIAL; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY STENOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 24044533237     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh906     Document Type: Article

References (21)

1. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697-701
2. Farias MA, McClellan W, Soucie JM, Mitch WE. A prospective comparison of methods for determining if cardiovascular disease is a predictor of mortality in dialysis patients. Am J Kidney Dis 1994; 23: 382-388
3. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-1615
4. Nishimura M, Hashimoto T, Kobayashi H et al. Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients. Kidney Int 2004; 66: 811-819
5. Zoccali C, Mallamaci F, Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int 2003; [Suppl 85]: S105-S110
6. Shlipak MG, Fried LF, Crump C et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92
7. Landray MJ, Wheeler DC, Lip GY et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: The chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 2004; 43: 244-253
8. Song H, Tasaki H, Yashiro A et al. Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure. Clin Nephrol 2001; 56: 346-352
9. Zoccali C, Mallamaci F, Tripepi G et al. Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD). Kidney Int 2003; 64: 579-584
10. Sahn DJ, DeMaria A, Kisso J, Weyman A. The Committee on M-mode Standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083
11. Devereux RB, Koren MJ, deSimone G, Okin PM, Kligfield P. Methods for detection of left ventricular hypertrophy: Application to hypertensive heart disease. Eur Heart J 1993; 14 [Suppl D]: 8-15
12. Kishimoto T, Kubota Y, Matsushima T et al. Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 1. Evaluation of ELISA kit using outer membrane complex. J Jpn Assoc Infect Dis 1996; 70: 821-829
13. Numazaki K, Ikebe T, Chiba S. Detection of serum antibodies against Chlamydia pneumoniae by ELISA. Immunol Med Microbiol 1996; 14: 179-183
14. Kamamoto Y, Iijima Y, Miyashita N, Matsumoto A, Sakano T. Antigenic characterization of Chlamydia pneumoniae isolated in Hiroshima, Japan. Microbiol Immunol 1993; 37: 495-498
15. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44: 837-845
16. Qunibi WY, Nolan CA, Ayus JC. Cardiovascular calcification in patients with end-stage renal disease: A century-old phenomenon. Kidney Int Suppl 2002; Dec: 73-80
17. Nakamura S, Sasaki O, Nakahama H, Inenaga T, Kawano Y. Clinical characteristics and survival in end-stage renal disease patients with arteriosclerosis obliterans. Am J Nephrol 2002; 22: 422-428
18. Dowell S, Peeling R, Boman J et al. Standardizing Chlamydia pneumoniae assays: Recommendations from the Centres for Disease Control and Prevention (USA) and the Laboratory Center for Disease Control (Canada). Clin Infect Dis 2001; 33: 492-502
19. Kern DG, Neill MA, Schachter J. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest 1993; 104: 208-213
20. Wong YK, Sueur JM, Fall CH, Orfila J, Ward ME. The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae. J Clin Pathol 1999; 52: 99-102
21. Hoymans VY, Bosmans JM, Van Renterghem L et al. Importance of methodology in determination of Chlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis. J Clin Microbiol 2003; 41: 4049-4053